津膜科技(300334) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2025 was ¥55,239,429.82, representing a 52.60% increase year-over-year, while the year-to-date revenue decreased by 3.71% to ¥162,658,964.40[5] - Net profit attributable to shareholders for Q3 2025 was ¥1,125,856.88, a significant increase of 108.47% compared to the same period last year, with a year-to-date net profit of ¥1,341,019.47, up 111.28%[5] - Operating revenue decreased by 3.71% to ¥162,658,964.40 compared to the previous period[13] - Net profit increased by 123.91% to ¥2,818,804.79, a significant recovery from a loss in the previous period[14] - Total profit increased by 136.20% to ¥4,264,871.42, reflecting a turnaround in financial performance[14] Profitability and Margins - The company's gross profit margin improved to 36.61%, an increase of 8.47 percentage points from 28.14% in the previous year, driven by a rise in sales of separation membranes and water treatment equipment[8] - Other income decreased by 75.23% to ¥539,044.40, primarily due to reduced government subsidies[13] - The company reported a 902.21% increase in investment income to ¥995,032.74, driven by profits from joint ventures[13] Cash Flow and Liquidity - Cash flow from operating activities for the year-to-date period reached ¥5,291,492.62, marking a 118.01% increase compared to the previous year[5] - The company reported a significant increase in cash flow from operating activities, with cash received from sales reaching ¥223,435,157.89, compared to ¥143,312,683.58 in the previous period[34] - Net cash inflow from operating activities was $5,291,492.62, compared to a net outflow of $29,381,442.77 in the previous period, indicating a significant improvement[35] - Total cash inflow from financing activities reached $139,398,146.53, up from $40,100,000.00 in the prior period, reflecting strong capital raising efforts[35] - Cash and cash equivalents at the end of the period totaled $115,952,165.11, compared to $36,709,059.23 at the end of the previous period, showing a substantial increase[35] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,030,627,648.86, an increase of 8.68% from the previous year[5] - The total liabilities increased to ¥360,934,292.15 from ¥323,908,090.84, indicating a rise of 11.4%[28] - The total equity attributable to shareholders increased to ¥607,327,712.07 from ¥577,416,350.25, marking a growth of 5.2%[28] - Total cash inflow from operating activities of $241,880,485.04, compared to $149,758,027.85 previously, reflecting strong operational performance[35] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 15,439[16] - The largest shareholder, Hangmo Technology Development Group Co., Ltd., holds 23.63% of shares[16] - The major shareholder, Gaoxin Investment Development Co., Ltd., reduced its shareholding from 7.25% to 7.00%, selling a total of 767,100 shares, which represents 0.9925% of the company's total share capital during the reduction period from June 11, 2025, to September 10, 2025[19] Strategic Initiatives - The company plans to enhance the promotion of new products and expand its market presence in the industrial and municipal water treatment sectors in Q4 2025[9] - The company aims to improve overall operational performance by enhancing budget management and controlling costs and expenses[9] - The company changed its name to "Tianjin Membrane Technology Group Co., Ltd." to better align with its business strategy[18] Investment Activities - The company acquired a limited partnership interest in the Tianjin Membrane Green Venture Capital Fund for a total of 40 million yuan, holding 50% of the fund's total scale after the transaction[21] - The company introduced an investment of 135 million yuan into its wholly-owned subsidiary, Hebei Jinmem New Materials Technology Co., Ltd., through the Jing-Jin-Ji Membrane Materials Fund[22] Operational Efficiency - The accounts receivable decreased by 15.85% to ¥186,415,563.25, indicating improved collection efforts[11] - Operating costs decreased by 15.07% to ¥103,104,618.72, indicating improved cost management[13] - R&D expenses decreased by 6.08% to ¥18,688,910.42, suggesting a potential shift in investment strategy[13] - The company's research and development expenses were ¥18,688,910.42, slightly down from ¥19,899,426.96, indicating a focus on cost management[31] Audit and Compliance - The company did not undergo an audit for the third quarter financial report, which may impact investor confidence[36]